Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 84 of 108 entries
Sorted by: Best Match Show Resources per page
The evolving superiority of covered metallic stents for benign biliary strictures.

Hepatobiliary surgery and nutrition

Xu MM, Brown E, Tyberg A, Kahaleh M.
PMID: 28261600
Hepatobiliary Surg Nutr. 2017 Feb;6(1):63-64. doi: 10.21037/hbsn.2017.01.10.

No abstract available.

Cite
Xu MM, Brown E, Tyberg A, et al. The evolving superiority of covered metallic stents for benign biliary strictures. Hepatobiliary Surg Nutr. 2017;6(1):63-64doi: 10.21037/hbsn.2017.01.10.
Xu, M. M., Brown, E., Tyberg, A., & Kahaleh, M. (2017). The evolving superiority of covered metallic stents for benign biliary strictures. Hepatobiliary surgery and nutrition, 6(1), 63-64. https://doi.org/10.21037/hbsn.2017.01.10
Xu, Ming-Ming, et al. "The evolving superiority of covered metallic stents for benign biliary strictures." Hepatobiliary surgery and nutrition vol. 6,1 (2017): 63-64. doi: https://doi.org/10.21037/hbsn.2017.01.10
Xu MM, Brown E, Tyberg A, Kahaleh M. The evolving superiority of covered metallic stents for benign biliary strictures. Hepatobiliary Surg Nutr. 2017 Feb;6(1):63-64. doi: 10.21037/hbsn.2017.01.10. PMID: 28261600; PMCID: PMC5332214.
Copy Download .nbib Format: NLM
High-frequency oscillatory ventilation versus conventional ventilation: hemodynamic effects on lung and heart.

Physiological reports

Smailys A, Mitchell JR, Doig CJ, Tyberg JV, Belenkie I.
PMID: 24760513
Physiol Rep. 2014 Mar 27;2(3):e00259. doi: 10.1002/phy2.259. Print 2014.

Abstract High-frequency oscillatory ventilation (HFOV) may improve gas exchange in patients who are inadequately ventilated by conventional mechanical ventilation (CV); however, the hemodynamic consequences of switching to HFOV remain unclear. We compared the effects of CV and HFOV on...

Cite
Smailys A, Mitchell JR, Doig CJ, et al. High-frequency oscillatory ventilation versus conventional ventilation: hemodynamic effects on lung and heart. Physiol Rep. 2014;2(3):e00259doi: 10.1002/phy2.259.
Smailys, A., Mitchell, J. R., Doig, C. J., Tyberg, J. V., & Belenkie, I. (2014). High-frequency oscillatory ventilation versus conventional ventilation: hemodynamic effects on lung and heart. Physiological reports, 2(3), e00259. https://doi.org/10.1002/phy2.259
Smailys, Andrea, et al. "High-frequency oscillatory ventilation versus conventional ventilation: hemodynamic effects on lung and heart." Physiological reports vol. 2,3 (2014): e00259. doi: https://doi.org/10.1002/phy2.259
Smailys A, Mitchell JR, Doig CJ, Tyberg JV, Belenkie I. High-frequency oscillatory ventilation versus conventional ventilation: hemodynamic effects on lung and heart. Physiol Rep. 2014 Mar 27;2(3):e00259. doi: 10.1002/phy2.259. Print 2014. PMID: 24760513; PMCID: PMC4002239.
Copy Download .nbib Format: NLM
Endoscopic suturing for the prevention of stent migration in benign upper gastrointestinal conditions: a comparative multicenter study.

Endoscopy

Ngamruengphong S, Sharaiha RZ, Sethi A, Siddiqui AA, DiMaio CJ, Gonzalez S, Im J, Rogart JN, Jagroop S, Widmer J, Hasan RA, Laique S, Gonda T, Poneros J, Desai A, Tyberg A, Kumbhari V, El Zein M, Abdelgelil A, Besharati S, Hernaez R, Okolo PI, Singh V, Kalloo AN, Kahaleh M, Khashab MA.
PMID: 27494452
Endoscopy. 2016 Sep;48(9):808. doi: 10.1055/s-0042-113997. Epub 2016 Aug 05.

No abstract available.

Cite
Ngamruengphong S, Sharaiha RZ, Sethi A, et al. Endoscopic suturing for the prevention of stent migration in benign upper gastrointestinal conditions: a comparative multicenter study. Endoscopy. 2016;48(9):808doi: 10.1055/s-0042-113997.
Ngamruengphong, S., Sharaiha, R. Z., Sethi, A., Siddiqui, A. A., DiMaio, C. J., Gonzalez, S., Im, J., Rogart, J. N., Jagroop, S., Widmer, J., Hasan, R. A., Laique, S., Gonda, T., Poneros, J., Desai, A., Tyberg, A., Kumbhari, V., El Zein, M., Abdelgelil, A., Besharati, S., Hernaez, R., Okolo, P. I., Singh, V., Kalloo, A. N., Kahaleh, M., & Khashab, M. A. (2016). Endoscopic suturing for the prevention of stent migration in benign upper gastrointestinal conditions: a comparative multicenter study. Endoscopy, 48(9), 808. https://doi.org/10.1055/s-0042-113997
Ngamruengphong, Saowanee, et al. "Endoscopic suturing for the prevention of stent migration in benign upper gastrointestinal conditions: a comparative multicenter study." Endoscopy vol. 48,9 (2016): 808. doi: https://doi.org/10.1055/s-0042-113997
Ngamruengphong S, Sharaiha RZ, Sethi A, Siddiqui AA, DiMaio CJ, Gonzalez S, Im J, Rogart JN, Jagroop S, Widmer J, Hasan RA, Laique S, Gonda T, Poneros J, Desai A, Tyberg A, Kumbhari V, El Zein M, Abdelgelil A, Besharati S, Hernaez R, Okolo PI, Singh V, Kalloo AN, Kahaleh M, Khashab MA. Endoscopic suturing for the prevention of stent migration in benign upper gastrointestinal conditions: a comparative multicenter study. Endoscopy. 2016 Sep;48(9):808. doi: 10.1055/s-0042-113997. Epub 2016 Aug 05. PMID: 27494452.
Copy Download .nbib Format: NLM
Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion.

Data in brief

Khosravi MA, Abbasalipour M, Concordet JP, Berg JV, Zeinali S, Arashkia A, Buch T, Karimipoor M.
PMID: 31890812
Data Brief. 2019 Dec 11;28:104974. doi: 10.1016/j.dib.2019.104974. eCollection 2020 Feb.

The data presented in this article are related to the research article entitled as "Targeted deletion of the BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta-thalassemia disease " [1]. BCL11A...

Cite
Khosravi MA, Abbasalipour M, Concordet JP, et al. Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion. Data Brief. 2019;28:104974doi: 10.1016/j.dib.2019.104974.
Khosravi, M. A., Abbasalipour, M., Concordet, J. P., Berg, J. V., Zeinali, S., Arashkia, A., Buch, T., & Karimipoor, M. (2020). Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion. Data in brief, 28104974. https://doi.org/10.1016/j.dib.2019.104974
Khosravi, Mohammad Ali, et al. "Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion." Data in brief vol. 28 (2020): 104974. doi: https://doi.org/10.1016/j.dib.2019.104974
Khosravi MA, Abbasalipour M, Concordet JP, Berg JV, Zeinali S, Arashkia A, Buch T, Karimipoor M. Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion. Data Brief. 2019 Dec 11;28:104974. doi: 10.1016/j.dib.2019.104974. eCollection 2020 Feb. PMID: 31890812; PMCID: PMC6933148.
Copy Download .nbib Format: NLM
The attributable estimand: A new approach to account for intercurrent events.

Pharmaceutical statistics

Darken P, Nyberg J, Ballal S, Wright D.
PMID: 32198954
Pharm Stat. 2020 Sep;19(5):626-635. doi: 10.1002/pst.2019. Epub 2020 Mar 21.

The term "intercurrent events" has recently been used to describe events in clinical trials that may complicate the definition and calculation of the treatment effect estimand. This paper focuses on the use of an attributable estimand to address intercurrent...

Cite
Darken P, Nyberg J, Ballal S, et al. The attributable estimand: A new approach to account for intercurrent events. Pharm Stat. 2020;19(5):626-635doi: 10.1002/pst.2019.
Darken, P., Nyberg, J., Ballal, S., & Wright, D. (2020). The attributable estimand: A new approach to account for intercurrent events. Pharmaceutical statistics, 19(5), 626-635. https://doi.org/10.1002/pst.2019
Darken, Patrick, et al. "The attributable estimand: A new approach to account for intercurrent events." Pharmaceutical statistics vol. 19,5 (2020): 626-635. doi: https://doi.org/10.1002/pst.2019
Darken P, Nyberg J, Ballal S, Wright D. The attributable estimand: A new approach to account for intercurrent events. Pharm Stat. 2020 Sep;19(5):626-635. doi: 10.1002/pst.2019. Epub 2020 Mar 21. PMID: 32198954.
Copy Download .nbib Format: NLM
Alternative Approaches to the Assessment of the Systemic Circulation and Left Ventricular Performance: A Proof-of-Concept Study.

CJC open

Howell S, Burrowes LM, Belenkie I, Ter Keurs HEDJ, Lei L, Raj SR, Bouwmeester JC, Sheldon RS, Shrive NG, Tyberg JV.
PMID: 32159088
CJC Open. 2019 Feb 13;1(2):84-92. doi: 10.1016/j.cjco.2019.01.007. eCollection 2019 Mar.

BACKGROUND: The purpose of this article is to examine the systemic circulation and left ventricular (LV) performance by alternative, nonconventional approaches: systemic vascular conductance (METHODS: In 16 open-chest, anaesthetized pigs, we measured LV pressure (RESULTS: Sodium nitroprusside and isoproterenol...

Cite
Howell S, Burrowes LM, Belenkie I, et al. Alternative Approaches to the Assessment of the Systemic Circulation and Left Ventricular Performance: A Proof-of-Concept Study. CJC Open. 2019;1(2):84-92doi: 10.1016/j.cjco.2019.01.007.
Howell, S., Burrowes, L. M., Belenkie, I., Ter Keurs, H. E. D. J., Lei, L., Raj, S. R., Bouwmeester, J. C., Sheldon, R. S., Shrive, N. G., & Tyberg, J. V. (2019). Alternative Approaches to the Assessment of the Systemic Circulation and Left Ventricular Performance: A Proof-of-Concept Study. CJC open, 1(2), 84-92. https://doi.org/10.1016/j.cjco.2019.01.007
Howell, Sarah, et al. "Alternative Approaches to the Assessment of the Systemic Circulation and Left Ventricular Performance: A Proof-of-Concept Study." CJC open vol. 1,2 (2019): 84-92. doi: https://doi.org/10.1016/j.cjco.2019.01.007
Howell S, Burrowes LM, Belenkie I, Ter Keurs HEDJ, Lei L, Raj SR, Bouwmeester JC, Sheldon RS, Shrive NG, Tyberg JV. Alternative Approaches to the Assessment of the Systemic Circulation and Left Ventricular Performance: A Proof-of-Concept Study. CJC Open. 2019 Feb 13;1(2):84-92. doi: 10.1016/j.cjco.2019.01.007. eCollection 2019 Mar. PMID: 32159088; PMCID: PMC7063645.
Copy Download .nbib Format: NLM
Discontinuation of proton pump inhibitor use reduces the number of endoscopic procedures required for resolution of walled-off pancreatic necrosis.

Endoscopic ultrasound

Powers PC, Siddiqui A, Sharaiha RZ, Yang G, Dawod E, Novikov AA, Javia A, Edirisuriya C, Noor A, Mumtaz T, Iqbal U, Loren DE, Kowalski TE, Cosgrove N, Alicea Y, Tyberg A, Andalib I, Kahaleh M, Adler DG, Tuck E, McKenzie M, McCoy K.
PMID: 30719997
Endosc Ultrasound. 2019 May-Jun;8(3):194-198. doi: 10.4103/eus.eus_59_18.

BACKGROUND AND OBJECTIVES: Endoscopic drainage/debridement of symptomatic walled off necrosis (WON) using lumen-apposing metal stents (LAMS) is both safe and effective. While endoscopic management of WON is the standard approach to treatment, the ideal concomitant medical therapy remains unclear....

Cite
Powers PC, Siddiqui A, Sharaiha RZ, et al. Discontinuation of proton pump inhibitor use reduces the number of endoscopic procedures required for resolution of walled-off pancreatic necrosis. Endosc Ultrasound. 2019;8(3):194-198doi: 10.4103/eus.eus_59_18.
Powers, P. C., Siddiqui, A., Sharaiha, R. Z., Yang, G., Dawod, E., Novikov, A. A., Javia, A., Edirisuriya, C., Noor, A., Mumtaz, T., Iqbal, U., Loren, D. E., Kowalski, T. E., Cosgrove, N., Alicea, Y., Tyberg, A., Andalib, I., Kahaleh, M., Adler, D. G., Tuck, E., McKenzie, M., & McCoy, K. (2019). Discontinuation of proton pump inhibitor use reduces the number of endoscopic procedures required for resolution of walled-off pancreatic necrosis. Endoscopic ultrasound, 8(3), 194-198. https://doi.org/10.4103/eus.eus_59_18
Powers, Patrick C, et al. "Discontinuation of proton pump inhibitor use reduces the number of endoscopic procedures required for resolution of walled-off pancreatic necrosis." Endoscopic ultrasound vol. 8,3 (2019): 194-198. doi: https://doi.org/10.4103/eus.eus_59_18
Powers PC, Siddiqui A, Sharaiha RZ, Yang G, Dawod E, Novikov AA, Javia A, Edirisuriya C, Noor A, Mumtaz T, Iqbal U, Loren DE, Kowalski TE, Cosgrove N, Alicea Y, Tyberg A, Andalib I, Kahaleh M, Adler DG, Tuck E, McKenzie M, McCoy K. Discontinuation of proton pump inhibitor use reduces the number of endoscopic procedures required for resolution of walled-off pancreatic necrosis. Endosc Ultrasound. 2019 May-Jun;8(3):194-198. doi: 10.4103/eus.eus_59_18. PMID: 30719997; PMCID: PMC6589997.
Copy Download .nbib Format: NLM
EUS-guided pancreatic drainage: A steep learning curve.

Endoscopic ultrasound

Tyberg A, Bodiwala V, Kedia P, Tarnasky PR, Khan MA, Novikov A, Gaidhane M, Ardengh JC, Kahaleh M.
PMID: 32584312
Endosc Ultrasound. 2020 May-Jun;9(3):175-179. doi: 10.4103/eus.eus_3_20.

BACKGROUND AND OBJECTIVE: EUS-guided pancreatic drainage (EUS-PD) is an efficacious, acceptable risk option for patients with pancreatic duct obstruction who fail conventional ERCP. The aim of this study was to define the learning curve (LC) for EUS-PD.METHODS: Consecutive patients...

Cite
Tyberg A, Bodiwala V, Kedia P, et al. EUS-guided pancreatic drainage: A steep learning curve. Endosc Ultrasound. 2020;9(3):175-179doi: 10.4103/eus.eus_3_20.
Tyberg, A., Bodiwala, V., Kedia, P., Tarnasky, P. R., Khan, M. A., Novikov, A., Gaidhane, M., Ardengh, J. C., & Kahaleh, M. (2020). EUS-guided pancreatic drainage: A steep learning curve. Endoscopic ultrasound, 9(3), 175-179. https://doi.org/10.4103/eus.eus_3_20
Tyberg, Amy, et al. "EUS-guided pancreatic drainage: A steep learning curve." Endoscopic ultrasound vol. 9,3 (2020): 175-179. doi: https://doi.org/10.4103/eus.eus_3_20
Tyberg A, Bodiwala V, Kedia P, Tarnasky PR, Khan MA, Novikov A, Gaidhane M, Ardengh JC, Kahaleh M. EUS-guided pancreatic drainage: A steep learning curve. Endosc Ultrasound. 2020 May-Jun;9(3):175-179. doi: 10.4103/eus.eus_3_20. PMID: 32584312; PMCID: PMC7430898.
Copy Download .nbib Format: NLM
EUS-guided gallbladder drainage: a learning curve modified by technical progress.

Endoscopy international open

Tyberg A, Jha K, Shah S, Kedia P, Gaidhane M, Kahaleh M.
PMID: 31921991
Endosc Int Open. 2020 Jan;8(1):E92-E96. doi: 10.1055/a-1005-6602. Epub 2020 Jan 08.

No abstract available.

Cite
Tyberg A, Jha K, Shah S, et al. EUS-guided gallbladder drainage: a learning curve modified by technical progress. Endosc Int Open. 2020;8(1):E92-E96doi: 10.1055/a-1005-6602.
Tyberg, A., Jha, K., Shah, S., Kedia, P., Gaidhane, M., & Kahaleh, M. (2020). EUS-guided gallbladder drainage: a learning curve modified by technical progress. Endoscopy international open, 8(1), E92-E96. https://doi.org/10.1055/a-1005-6602
Tyberg, Amy, et al. "EUS-guided gallbladder drainage: a learning curve modified by technical progress." Endoscopy international open vol. 8,1 (2020): E92-E96. doi: https://doi.org/10.1055/a-1005-6602
Tyberg A, Jha K, Shah S, Kedia P, Gaidhane M, Kahaleh M. EUS-guided gallbladder drainage: a learning curve modified by technical progress. Endosc Int Open. 2020 Jan;8(1):E92-E96. doi: 10.1055/a-1005-6602. Epub 2020 Jan 08. PMID: 31921991; PMCID: PMC6949177.
Copy Download .nbib Format: NLM
Hepaticogastrostomy .

Endoscopic ultrasound

Tyberg A, Napoleon B, Robles-Medranda C, Shah JN, Bories E, Kumta NA, Yague AS, Vazquez-Sequeiros E, Lakhtakia S, El Chafic AH, Shah SL, Sameera S, Tawadros A, Ardengh JC, Kedia P, Gaidhane M, Giovannini M, Kahaleh M.
PMID: 34494590
Endosc Ultrasound. 2021 Sep 08; doi: 10.4103/EUS-D-21-00006. Epub 2021 Sep 08.

BACKGROUND AND OBJECTIVES: EUS-guided biliary drainage (EUS-BD) offers minimally invasive decompression when conventional endoscopic retrograde cholangiopancreatography fails. Stents can be placed from the intrahepatic ducts into the stomach (hepaticogastrostomy [HG]) or from the extrahepatic bile duct into the small...

Cite
Tyberg A, Napoleon B, Robles-Medranda C, et al. Hepaticogastrostomy . Endosc Ultrasound. 2021;doi: 10.4103/EUS-D-21-00006.
Tyberg, A., Napoleon, B., Robles-Medranda, C., Shah, J. N., Bories, E., Kumta, N. A., Yague, A. S., Vazquez-Sequeiros, E., Lakhtakia, S., El Chafic, A. H., Shah, S. L., Sameera, S., Tawadros, A., Ardengh, J. C., Kedia, P., Gaidhane, M., Giovannini, M., & Kahaleh, M. (2021). Hepaticogastrostomy . Endoscopic ultrasound, . https://doi.org/10.4103/EUS-D-21-00006
Tyberg, Amy, et al. "Hepaticogastrostomy ." Endoscopic ultrasound vol. (2021). doi: https://doi.org/10.4103/EUS-D-21-00006
Tyberg A, Napoleon B, Robles-Medranda C, Shah JN, Bories E, Kumta NA, Yague AS, Vazquez-Sequeiros E, Lakhtakia S, El Chafic AH, Shah SL, Sameera S, Tawadros A, Ardengh JC, Kedia P, Gaidhane M, Giovannini M, Kahaleh M. Hepaticogastrostomy . Endosc Ultrasound. 2021 Sep 08; doi: 10.4103/EUS-D-21-00006. Epub 2021 Sep 08. PMID: 34494590.
Copy Download .nbib Format: NLM
Personalized Approach to the Role of Endoscopic Ultrasound in the Diagnosis and Management of Pancreaticobiliary Malignancies.

Journal of personalized medicine

Makar M, Zhao E, Tyberg A.
PMID: 33806458
J Pers Med. 2021 Mar 04;11(3). doi: 10.3390/jpm11030180.

Pancreaticobiliary malignancies arise from different areas within the pancreas and biliary tree. Endoscopic ultrasound (EUS) is a well-recognized diagnostic and therapeutic modality in the treatment of pancreaticobiliary diseases, and more specifically, pancreaticobiliary malignancies. Traditionally used for diagnostic purposes, EUS...

Cite
Makar M, Zhao E, Tyberg A. Personalized Approach to the Role of Endoscopic Ultrasound in the Diagnosis and Management of Pancreaticobiliary Malignancies. J Pers Med. 2021;11(3)doi: 10.3390/jpm11030180.
Makar, M., Zhao, E., & Tyberg, A. (2021). Personalized Approach to the Role of Endoscopic Ultrasound in the Diagnosis and Management of Pancreaticobiliary Malignancies. Journal of personalized medicine, 11(3), . https://doi.org/10.3390/jpm11030180
Makar, Michael, et al. "Personalized Approach to the Role of Endoscopic Ultrasound in the Diagnosis and Management of Pancreaticobiliary Malignancies." Journal of personalized medicine vol. 11,3 (2021). doi: https://doi.org/10.3390/jpm11030180
Makar M, Zhao E, Tyberg A. Personalized Approach to the Role of Endoscopic Ultrasound in the Diagnosis and Management of Pancreaticobiliary Malignancies. J Pers Med. 2021 Mar 04;11(3). doi: 10.3390/jpm11030180. PMID: 33806458; PMCID: PMC7999426.
Copy Download .nbib Format: NLM
Single session per oral endoscopic myotomy and trans oral incisionless fundoplication - can we prevent reflux in patients with achalasia?.

Endoscopy international open

Benias PC, Kumbhari V, Kumta NA, Sethi A, D'Souza LS, Tyberg A, Brewer Gutierrez O, Miller LS, Carr-Locke DL, Khashab MA.
PMID: 34079863
Endosc Int Open. 2021 Jun;9(6):E828-E835. doi: 10.1055/a-1395-5667. Epub 2021 May 27.

No abstract available.

Cite
Benias PC, Kumbhari V, Kumta NA, et al. Single session per oral endoscopic myotomy and trans oral incisionless fundoplication - can we prevent reflux in patients with achalasia?. Endosc Int Open. 2021;9(6):E828-E835doi: 10.1055/a-1395-5667.
Benias, P. C., Kumbhari, V., Kumta, N. A., Sethi, A., D'Souza, L. S., Tyberg, A., Brewer Gutierrez, O., Miller, L. S., Carr-Locke, D. L., & Khashab, M. A. (2021). Single session per oral endoscopic myotomy and trans oral incisionless fundoplication - can we prevent reflux in patients with achalasia?. Endoscopy international open, 9(6), E828-E835. https://doi.org/10.1055/a-1395-5667
Benias, Petros C, et al. "Single session per oral endoscopic myotomy and trans oral incisionless fundoplication - can we prevent reflux in patients with achalasia?." Endoscopy international open vol. 9,6 (2021): E828-E835. doi: https://doi.org/10.1055/a-1395-5667
Benias PC, Kumbhari V, Kumta NA, Sethi A, D'Souza LS, Tyberg A, Brewer Gutierrez O, Miller LS, Carr-Locke DL, Khashab MA. Single session per oral endoscopic myotomy and trans oral incisionless fundoplication - can we prevent reflux in patients with achalasia?. Endosc Int Open. 2021 Jun;9(6):E828-E835. doi: 10.1055/a-1395-5667. Epub 2021 May 27. PMID: 34079863; PMCID: PMC8159615.
Copy Download .nbib Format: NLM
Showing 73 to 84 of 108 entries